植込み型心臓モニター市場：適応症別（心不整脈、心房細動、てんかん、原因不明の転倒）、エンドユーザー別（病院・クリニック、家庭環境、外来外科センター（Ascs））。世界の機会分析および産業予測、2020-2030年

Implantable Cardiac Monitors Market By Indication (Cardiac Arrrythmias, Atrial Fribrillation, Epilepsy And Unexplained Falls), By End User (Hospitals And Clinics, Home Settings, Ambulatory Surgical Centers (Ascs)): Global Opportunity Analysis and Industry Forecast, 2020-2030

植込み型心臓モニターの世界市場は、2020年に5億0200万ドル、2021年から2030年にかけてCAGR7.2%を記録し、2030年には9億7442万ドルに達すると予測されています。植込み型心臓モニター（ICM）は、植込み型ループ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,769 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	115	英語

サマリー

植込み型心臓モニターの世界市場は、2020年に5億0200万ドル、2021年から2030年にかけてCAGR7.2%を記録し、2030年には9億7442万ドルに達すると予測されています。
植込み型心臓モニター（ICM）は、植込み型ループレコーダー（ILR）とも呼ばれ、心臓の電気的活動を記録するために使用される小型監視装置である。この装置は、患者の胸の皮膚の下に埋め込まれ、心臓の電気的活動が記録されます。この装置は、医師が設定した範囲内で心拍数を調整することで起動しますが、ボタンを押すことで外部からも起動できます。これらの記録は、医師が異常な心拍を分析・特定し、心筋梗塞や心房細動の危険性がある患者を正確にモニターするために使用されます。
このデバイスが提供する長寿命、患者を入院させる必要のないこのモニターの移植可能な性質、および患者が日常活動を行う際のモニタリング機能が、市場の成長を後押ししています。また、心房細動患者の増加、心筋梗塞の流行、不健康なライフスタイルも市場の成長に寄与しています。しかし、代替治療法の入手可能性や医療機器のコスト高が、市場成長の阻害要因となっています。逆に、これらのデバイスや心疾患管理のための治療オプションに関する患者の意識の高まりは、予測期間中に市場に有利な成長機会を提供すると期待されています。
ICMの世界市場は、適応症、エンドユーザー、地域に基づいて区分されます。適応症によれば、心臓不整脈、心房細動、てんかん・原因不明の転倒に分類されます。エンドユーザーによって、病院、心臓センター＆クリニック、外来外科センターに分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

ステークホルダーにとっての主なメリット

本レポートでは、現在の市場動向と2020年から2030年までの将来予測を詳細に定量分析し、有力な市場機会の特定を支援します。
様々な地域の詳細な分析により、現在の動向を詳細に把握し、ステークホルダーが地域別の計画を策定できるようにすることが期待されます。
ICMs市場の成長を促進し、抑制する要因の包括的な分析が提供されます。
様々な地域の広範な分析は、企業が戦略的にビジネスの動きを計画することを可能にする洞察を提供します。
主要な市場プレイヤーとその戦略は、市場の競争的展望を理解するために分析されています。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiac Arrrythmias
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Atrial Fribrillation
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Epilepsy And Unexplained Falls
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals And Clinics
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Home Settings
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Ambulatory Surgical Centers (Ascs)
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Indication
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Indication
6.2.4.1.2 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Indication
6.2.4.2.2 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Indication
6.2.4.3.2 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Indication
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Indication
6.3.4.1.2 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Indication
6.3.4.2.2 Market size and forecast, by End User
6.3.4.3 United Kingdom
6.3.4.3.1 Market size and forecast, by Indication
6.3.4.3.2 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Indication
6.3.4.4.2 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Indication
6.3.4.5.2 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Indication
6.3.4.6.2 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Indication
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Indication
6.4.4.1.2 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Indication
6.4.4.2.2 Market size and forecast, by End User
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Indication
6.4.4.3.2 Market size and forecast, by End User
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Indication
6.4.4.4.2 Market size and forecast, by End User
6.4.4.5 South Africa
6.4.4.5.1 Market size and forecast, by Indication
6.4.4.5.2 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Indication
6.4.4.6.2 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Indication
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Indication
6.5.4.1.2 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Indication
6.5.4.2.2 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Indication
6.5.4.3.2 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Indication
6.5.4.4.2 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 ABBOTT LABORATORIES
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Boston Scientific Corporation
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 EDWARDS LIFE SCIENCE CORPORATION
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 2. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR CARDIAC ARRRYTHMIAS, BY REGION , 2020-2030,($MILLION)
TABLE 3. IMPLANTABLE CARDIAC MONITORS MARKET CARDIAC ARRRYTHMIAS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR ATRIAL FRIBRILLATION, BY REGION , 2020-2030,($MILLION)
TABLE 5. IMPLANTABLE CARDIAC MONITORS MARKET ATRIAL FRIBRILLATION BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR EPILEPSY AND UNEXPLAINED FALLS, BY REGION , 2020-2030,($MILLION)
TABLE 7. IMPLANTABLE CARDIAC MONITORS MARKET EPILEPSY AND UNEXPLAINED FALLS BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 9. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 10. IMPLANTABLE CARDIAC MONITORS MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR HOME SETTINGS, BY REGION , 2020-2030,($MILLION)
TABLE 12. IMPLANTABLE CARDIAC MONITORS MARKET HOME SETTINGS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION , 2020-2030,($MILLION)
TABLE 14. IMPLANTABLE CARDIAC MONITORS MARKET AMBULATORY SURGICAL CENTERS (ASCS) BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 16. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 17. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 18. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. U.S. IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 20. U.S. IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 21. CANADA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 22. CANADA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 23. MEXICO IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 24. MEXICO IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 25. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 26. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 27. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 28. GERMANY IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 29. GERMANY IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 30. FRANCE IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 31. FRANCE IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 32. UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 33. UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 34. ITALY IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 35. ITALY IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 36. SPAIN IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 37. SPAIN IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 38. REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 39. REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 40. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 41. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 42. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 43. JAPAN IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 44. JAPAN IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 45. CHINA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 46. CHINA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 47. AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 48. AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 49. INDIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 50. INDIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 52. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 53. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 54. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 55. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 56. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 57. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 58. BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 59. BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 60. SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 61. SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 62. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 63. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 64. REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 65. REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 66.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 67.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 68.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 69.ABBOTT LABORATORIES: NET SALES,
TABLE 70.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 71.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 72.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 73.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 74.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 75.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 76.EDWARDS LIFE SCIENCE CORPORATION: COMPANY SNAPSHOT
TABLE 77.EDWARDS LIFE SCIENCE CORPORATION: OPERATING SEGMENTS
TABLE 78.EDWARDS LIFE SCIENCE CORPORATION: PRODUCT PORTFOLIO
TABLE 79.EDWARDS LIFE SCIENCE CORPORATION: NET SALES,
TABLE 80.EDWARDS LIFE SCIENCE CORPORATION: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.IMPLANTABLE CARDIAC MONITORS MARKET SEGMENTATION
FIGURE 2.IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030
FIGURE 3.IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.IMPLANTABLE CARDIAC MONITORS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.IMPLANTABLE CARDIAC MONITORS MARKET,BY INDICATION,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF CARDIAC ARRRYTHMIAS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ATRIAL FRIBRILLATION IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EPILEPSY AND UNEXPLAINED FALLS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 15.IMPLANTABLE CARDIAC MONITORS MARKET,BY END USER,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOME SETTINGS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS (ASCS) IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 19.IMPLANTABLE CARDIAC MONITORS MARKET BY REGION,2020
FIGURE 20.U.S. IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 21.CANADA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 22.MEXICO IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 23.GERMANY IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 24.FRANCE IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 25.UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 26.ITALY IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 27.SPAIN IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 28.REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 29.JAPAN IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 30.CHINA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 31.AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 32.INDIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 33.SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 35.BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 36.SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 37.SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 38.REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 43.COMPETITIVE DASHBOARD
FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 46.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 47.EDWARDS LIFE SCIENCE CORPORATION.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global implantable cardiac monitors market was valued at $500.02 million in 2020, and is projected to reach $974.42 million by 2030, registering a CAGR of 7.2% from 2021 to 2030.
An implantable cardiac monitor(ICM), also known as implantable loop recorder (ILR), is a small monitoring device used to record electrical activity of the heart. The device is embedded under the chest skin of the patient through which the electrical activity of heart is recorded. The device is activated either by adjusting the heart rate according to the range set by the physician or can be externally triggered with the push of a button. These recordings are used by physicians to analyze and identify abnormal heart rhythm, precisely to monitor patients who are at risk of myocardial infraction and atrial fibrillation.
Longevity offered by this device, implantable nature of this monitor which does not require patient to be admitted to the hospital, and ability of monitoring patient while they perform daily activities drive the growth of the market. Moreover, increase in incidence of patients suffering from atrial fibrillation, prevalence of myocardial infraction, and unhealthy lifestyle contribute toward the growth of the market. However, availability of alternative mode of treatment and inflated cost of this device are the major barriers that hinder the growth of the market. Conversely, increase in awareness among patients about these devices and treatment options for management of cardiac disorders are expected to offer lucrative growth opportunities for market during the forecast period.
The global ICMs market is segmented on the basis of indication, end user, and region. According to indication, it is categorized into cardiac arrhythmias, atrial fibrillation, and epilepsy & unexplained falls. Depending on end user, it is classified into hospitals, cardiac centers & clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the ICMs market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（二次医療）の最新刊レポート

Allied Market Research社の二次医療分野での最新刊レポート

本レポートと同じKEY WORD（ambulatory）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

植込み型心臓モニター市場：適応症別（心不整脈、心房細動、てんかん、原因不明の転倒）、エンドユーザー別（病院・クリニック、家庭環境、外来外科センター（Ascs））。世界の機会分析および産業予測、2020-2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（二次医療）の最新刊レポート

Allied Market Research社の二次医療分野での最新刊レポート

本レポートと同じKEY WORD（ambulatory）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?